| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study.
|
Lancet
|
2012
|
11.82
|
|
2
|
Changes in the treatment responses to artesunate-mefloquine on the northwestern border of Thailand during 13 years of continuous deployment.
|
PLoS One
|
2009
|
5.81
|
|
3
|
Deployment of early diagnosis and mefloquine-artesunate treatment of falciparum malaria in Thailand: the Tak Malaria Initiative.
|
PLoS Med
|
2006
|
3.83
|
|
4
|
Efficacy and safety of artemether-lumefantrine compared with quinine in pregnant women with uncomplicated Plasmodium falciparum malaria: an open-label, randomised, non-inferiority trial.
|
Lancet Infect Dis
|
2010
|
2.24
|
|
5
|
Plasmodium vivax recurrence following falciparum and mixed species malaria: risk factors and effect of antimalarial kinetics.
|
Clin Infect Dis
|
2011
|
2.16
|
|
6
|
A randomized trial of artemether-lumefantrine versus mefloquine-artesunate for the treatment of uncomplicated multi-drug resistant Plasmodium falciparum on the western border of Thailand.
|
Malar J
|
2005
|
2.05
|
|
7
|
Safety and efficacy of dihydroartemisinin-piperaquine in falciparum malaria: a prospective multi-centre individual patient data analysis.
|
PLoS One
|
2009
|
2.05
|
|
8
|
The pharmacokinetics of artemether and lumefantrine in pregnant women with uncomplicated falciparum malaria.
|
Eur J Clin Pharmacol
|
2006
|
1.80
|
|
9
|
A randomised controlled trial of artemether-lumefantrine versus artesunate for uncomplicated plasmodium falciparum treatment in pregnancy.
|
PLoS Med
|
2008
|
1.71
|
|
10
|
Dihydroartemisinin-piperaquine versus chloroquine in the treatment of Plasmodium vivax malaria in Thailand: a randomized controlled trial.
|
Clin Infect Dis
|
2011
|
1.64
|
|
11
|
Population pharmacokinetics of lumefantrine in pregnant women treated with artemether-lumefantrine for uncomplicated Plasmodium falciparum malaria.
|
Antimicrob Agents Chemother
|
2009
|
1.61
|
|
12
|
Randomized, double-blind, placebo-controlled trial of monthly versus bimonthly dihydroartemisinin-piperaquine chemoprevention in adults at high risk of malaria.
|
Antimicrob Agents Chemother
|
2012
|
1.59
|
|
13
|
World Antimalarial Resistance Network I: clinical efficacy of antimalarial drugs.
|
Malar J
|
2007
|
1.56
|
|
14
|
Primaquine: the risks and the benefits.
|
Malar J
|
2014
|
1.51
|
|
15
|
Intrahost selection of Plasmodium falciparum pfmdr1 alleles after antimalarial treatment on the northwestern border of Thailand.
|
J Infect Dis
|
2006
|
1.49
|
|
16
|
Effect of early detection and treatment on malaria related maternal mortality on the north-western border of Thailand 1986-2010.
|
PLoS One
|
2012
|
1.44
|
|
17
|
Arthropod borne disease: the leading cause of fever in pregnancy on the Thai-Burmese border.
|
PLoS Negl Trop Dis
|
2010
|
1.39
|
|
18
|
A randomized comparison of artesunate-atovaquone-proguanil versus quinine in treatment for uncomplicated falciparum malaria during pregnancy.
|
J Infect Dis
|
2005
|
1.27
|
|
19
|
Mass primaquine treatment to eliminate vivax malaria: lessons from the past.
|
Malar J
|
2014
|
1.27
|
|
20
|
Optimal sampling designs for estimation of Plasmodium falciparum clearance rates in patients treated with artemisinin derivatives.
|
Malar J
|
2013
|
1.21
|
|
21
|
Electrocardiographic safety evaluation of dihydroartemisinin piperaquine in the treatment of uncomplicated falciparum malaria.
|
Am J Trop Med Hyg
|
2007
|
1.20
|
|
22
|
Tolerability and safety of artesunate-amodiaquine and artemether-lumefantrine fixed dose combinations for the treatment of uncomplicated Plasmodium falciparum malaria: two open-label, randomized trials in Nimba County, Liberia.
|
Malar J
|
2013
|
1.15
|
|
23
|
Ex vivo susceptibility of Plasmodium falciparum to antimalarial drugs in western, northern, and eastern Cambodia, 2011-2012: association with molecular markers.
|
Antimicrob Agents Chemother
|
2013
|
1.08
|
|
24
|
Efficacy of artesunate-amodiaquine and artemether-lumefantrine fixed-dose combinations for the treatment of uncomplicated Plasmodium falciparum malaria among children aged six to 59 months in Nimba County, Liberia: an open-label randomized non-inferiority trial.
|
Malar J
|
2013
|
1.05
|
|
25
|
Thrombocytopaenia in pregnant women with malaria on the Thai-Burmese border.
|
Malar J
|
2008
|
1.01
|
|
26
|
Assessment of therapeutic responses to gametocytocidal drugs in Plasmodium falciparum malaria.
|
Malar J
|
2014
|
1.01
|
|
27
|
Susceptibility of community-acquired pathogens to antibiotics in Africa and Asia in neonates--an alarmingly short review.
|
Trop Med Int Health
|
2010
|
1.00
|
|
28
|
The effect of dosing strategies on the therapeutic efficacy of artesunate-amodiaquine for uncomplicated malaria: a meta-analysis of individual patient data.
|
BMC Med
|
2015
|
0.99
|
|
29
|
Susceptibility of bacterial isolates from community-acquired infections in sub-Saharan Africa and Asia to macrolide antibiotics.
|
Trop Med Int Health
|
2011
|
0.91
|
|
30
|
Baseline data of parasite clearance in patients with falciparum malaria treated with an artemisinin derivative: an individual patient data meta-analysis.
|
Malar J
|
2015
|
0.91
|
|
31
|
Diagnostic and treatment difficulties of pyelonephritis in pregnancy in resource-limited settings.
|
Am J Trop Med Hyg
|
2010
|
0.87
|
|
32
|
Knowledge and acceptability of the rectal treatment route in Laos and its application for pre-referral emergency malaria treatment.
|
Malar J
|
2010
|
0.83
|
|
33
|
Comparability of tympanic and oral mercury thermometers at high ambient temperatures.
|
BMC Res Notes
|
2012
|
0.82
|
|
34
|
Clinically uncomplicated Plasmodium falciparum malaria with high schizontaemia: a case report.
|
Malar J
|
2008
|
0.81
|
|
35
|
Introducing the concept of a new pre-referral treatment for severely ill febrile children at community level: a sociological approach in Guinea-Bissau.
|
Malar J
|
2014
|
0.77
|
|
36
|
Toxic brainstem encephalopathy after artemisinin treatment for breast cancer.
|
Ann Neurol
|
2006
|
0.76
|